- Drugs
- Wednesday, 18 Dec 2019
Medical Marijuana, Inc. Appoints New Chief Financial Officer
Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that it has promoted its VP of Corporate Finance Brooke Beers to Chief Financial Officer of the Company.
"Brooke's contributions to the Company have been extraordinary," said Medical Marijuana, Inc. COO Blake Schroeder. "He's helped us overcome several financial obstacles that many cannabis companies face every day and he has helped us significantly improve our public reporting practices to increase transparency."
Beers was hired by Medical Marijuana, Inc. in 2017 and has since been leading the Company's accounting department, handling the Company's budget management, public financial reports, e-commerce offerings, and forecasting needs.
"Working with the Medical Marijuana, Inc. team has been an incredibly rewarding experience," said Beers. "Last December, the Brightfield Group reported that our Company represents 10 percent of the entire CBD market and I'm proud to be a part of that financial milestone and many more to come. It's encouraging to work with a large group of highly motivated professionals and claim our stake in the global CBD industry."
Related Industry Updates
Pulmonary Arterial Hypertension Market is expected to reach US$ 10,889.08 million by 2028
Jan 02, 2023
Radiopharmaceutical Theragnostics Market is expected to reach US$ 3,441.97 million by 2028
Mar 27, 2023
111 Inc. Hosts 2019 Online Pharmaceuticals and Healthcare Summit
Dec 20, 2019
Antifungal Drugs Market is expected to reach US$ 13,997.4 Million in 2028
Jan 16, 2023
Datroway (datopotamab deruxtecan) Earns FDA Priority Review
Feb 17, 2026
Complementary and Alternative Medicine Market Players to See Huge Investments Opportunities by 2027 | Columbia Nutritional Inc.,Helio USA Inc.,Herb Pharm,Herbal Hills,Nordic Naturals & More
Apr 27, 2021
Clinical Trial Imaging Market is expected to reach US$ 2,480.32 million by 2028
May 23, 2023